Search results for "Anxiety disorder"

showing 10 items of 255 documents

Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender.

2021

Silexan®, a proprietary essential oil manufactured by steam distillation from Lavandula angustifolia flowers showed pronounced anxiolytic effects in patients with subthreshold anxiety disorders and was also efficacious in patients with Generalized Anxiety disorder (GAD). Moreover, evidences for antidepressant-like properties of Silexan® have been observed in anxious patients suffering from comorbid depressive symptoms and in patients with mixed anxiety-depression disorder (ICD-10 F41.2). In accordance with the clinical data Silexan® is active in several behavioral models in rodents at rather low concentrations indicating potent anxiolytic and antidepressive properties. As possible mechanism…

0301 basic medicineMAPK/ERK pathwayGeneralized anxiety disordermedicine.drug_classPregabalinFlowersPharmacologyAnxietyCREBAnxiolytic03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicinemedicineOils VolatileAnimalsHumansPlant OilsbiologyVoltage-dependent calcium channelChemistryDepressionCell Biologymedicine.diseaseCalcium Channel BlockersAntidepressive Agents030104 developmental biologyLavandulaMechanism of actionAnti-Anxiety Agentsbiology.proteinAntidepressantCalcium Channelsmedicine.symptom030217 neurology & neurosurgerymedicine.drugNeurochemistry international
researchProduct

Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat.

2016

The brain circuits underlying behavioral fear have been extensively studied over the last decades. Although the vast majority of experimental studies assess fear as a transient state of apprehension in response to a discrete threat, such phasic states of fear can shift to a sustained anxious apprehension, particularly in face of diffuse cues with unpredictable environmental contingencies. Unpredictability, in turn, is considered an important variable contributing to anxiety disorders. The networks of the extended amygdala have been suggested keys to the control of phasic and sustained states of fear, although the underlying synaptic pathways and mechanisms remain poorly understood. Here, we…

0301 basic medicineMaleReflex StartleAnxietyAmygdalaDevelopmental psychology03 medical and health sciencesCellular and Molecular NeuroscienceMice0302 clinical medicineExtended amygdalaReceptor Cannabinoid CB1medicineAnimalsMolecular BiologyFear processing in the brainCannabinoidsFearmedicine.diseaseAmygdalaEndocannabinoid systemAnxiety DisordersPsychiatry and Mental healthStria terminalis030104 developmental biologymedicine.anatomical_structureSchizophreniaBehavioral medicineAnxietySeptal Nucleimedicine.symptomCuesPsychologyNeuroscience030217 neurology & neurosurgeryEndocannabinoidsMolecular psychiatry
researchProduct

GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathw…

2017

Contains fulltext : 177350.pdf (Publisher’s version ) (Closed access) The molecular genetics of panic disorder (PD) with and without agoraphobia (AG) are still largely unknown and progress is hampered by small sample sizes. We therefore performed a genome-wide association study with a dimensional, PD/AG-related anxiety phenotype based on the Agoraphobia Cognition Questionnaire (ACQ) in a sample of 1370 healthy German volunteers of the CRC TRR58 MEGA study wave 1. A genome-wide significant association was found between ACQ and single non-coding nucleotide variants of the GLRB gene (rs78726293, P=3.3 x 10-8; rs191260602, P=3.9 x 10-8). We followed up on this finding in a larger dimensional AC…

0301 basic medicineMaleStartle responseReflex StartleQH301 BiologyGenome-wide association studyGene mutationAnxiety0302 clinical medicineCognitionReceptors GlycineGene FrequencyGermanyGWASHyperekplexiaGeneticsPanic disordermedicine.diagnostic_testStartleBrainFearGLRBAnxiety DisordersPsychiatry and Mental healthSchizophreniaUrological cancers Radboud Institute for Health Sciences [Radboudumc 15]Panic DisorderFemalemedicine.symptomPsychologyBDCRC0321 Neuroscience. Biological psychiatry. NeuropsychiatryClinical psychologyAdultGenotypeNDASQH426 Genetics03 medical and health sciencesCellular and Molecular NeuroscienceQH301Fear networkSpastic mousemedicineHumansGenetic Predisposition to DiseaseMolecular BiologyQH426AgoraphobiaAllelesNeurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7]Panic disorderOther Research Radboud Institute for Health Sciences [Radboudumc 0]medicine.diseaseStartle reaction030104 developmental biologyMCPCase-Control StudiesMutationRC0321030217 neurology & neurosurgeryAgoraphobiaGenome-Wide Association StudyMolecular psychiatry
researchProduct

Typical symptom change patterns and their predictors in patients with social anxiety disorder: A latent class analysis

2020

Abstract Objectives The use of trajectories and analysis of change patterns is a promising way toward better differentiation of subgroups in psychotherapy studies. Research on change patterns in social anxiety disorder (SAD) are still rare, although SAD is one of the most common mental disorders. In a secondary analysis of data from the SOPHO-NET-trial (ISRCTN53517394) this study aimed to investigate change patterns and their predictors in a sample of SAD patients. Methods Patients with SAD (N = 357) were randomly assigned to cognitive-behavioral or psychodynamic therapy. The Liebowitz Social Anxiety Scale (LSAS) was assessed at 1st session (pre), 8th session, 15th session and at the end of…

050103 clinical psychologyPsychodynamic psychotherapy05 social sciencesSocial anxietyChange patternsPhobia SocialLiebowitz social anxiety scaleAnxietyLogistic regressionAnxiety DisordersLatent class model030227 psychiatry3. Good healthPsychotherapy03 medical and health sciencesPsychiatry and Mental healthClinical Psychology0302 clinical medicineLatent Class AnalysisSecondary analysisHumans0501 psychology and cognitive sciencesIn patientPsychologyClinical psychologyJournal of Anxiety Disorders
researchProduct

Treating anxiety disorders by emotion-focused psychodynamic psychotherapy (EFPP)-An integrative, transdiagnostic approach.

2018

Anxiety disorders are characterized by high levels of anxiety and avoidance of anxiety-inducing situations and of negative emotions such as anger. Emotion-focused therapy (EFT) and psychodynamic psychotherapy (PP) have underscored the therapeutic significance of processing and transforming repressed or disowned conflicted or painful emotions. Although PP provides sophisticated means of processing intrapsychic and interpersonal conflict, EFT has empirically tested a set of techniques to access, deepen, symbolize, and transform emotions consistent with current conceptualizations of emotions and memory. Based on our clinical experience, we propose that an integrative emotion-focused and psycho…

050103 clinical psychologyPsychodynamic psychotherapyEmotion-Focused TherapyPsychotherapistSense of agencymedia_common.quotation_subject05 social sciencesInterpersonal communicationAngerAnxiety Disorders030227 psychiatry03 medical and health sciencesClinical Psychology0302 clinical medicinemedicineAnxietyHumans0501 psychology and cognitive sciencesmedicine.symptomPsychologySet (psychology)Psychotherapy PsychodynamicIntrapsychicIntrapersonal communicationmedia_commonClinical psychologypsychotherapy
researchProduct

The Social Phobia Psychotherapy Research Network

2008

This paper presents the Social Phobia Psychotherapy Research Network. The research program encompasses a coordinated group of studies adopting a standard protocol and an agreed-on set of standardized measures for the assessment and treatment of social phobia (SP). In the central project (study A), a multicenter randomized controlled trial, refined models of manualized cognitive-behavioral therapy and manualized short-term psychodynamic psychotherapy are compared in the treatment of SP. A sample of 512 outpatients will be randomized to either cognitive-behavioral therapy, short-term psychodynamic psychotherapy or waiting list. Assessments will be made at baseline, at the end of treatment and…

050103 clinical psychologyPsychotherapistCost effectivenessmedicine.medical_treatmentlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicine0501 psychology and cognitive sciencesApplied PsychologyPsychodynamic psychotherapy05 social sciencesSocial environmentGeneral Medicinemedicine.disease030227 psychiatry3. Good healthClinical trialCognitive behavioral therapyPsychiatry and Mental healthClinical PsychologyCognitive therapyPsychologyAnxiety disorderClinical psychologyPsychotherapy and Psychosomatics
researchProduct

2019

Background: Depression and anxiety are highly prevalent and often co-occur. Several studies indicate the potential of disorder-specific psychological interventions for the prevention of each of these disorders. To treat comorbidity, transdiagnostic treatment concepts seem to be a promising approach, however, evidence for transdiagnostic concepts of prevention remains inconclusive. Internet- and mobile-based interventions (IMIs) may be an effective means to deliver psychological interventions on a large scale for the prevention of common mental disorders (CMDs) such as depression and anxiety. IMIs have been shown to be effective in treating CMDs, e.g. in reducing symptoms of depression and a…

050103 clinical psychologymedicine.medical_specialtyCost effectivenessbusiness.industry05 social sciencesPsychological interventionHealth Informaticsmedicine.disease3. Good healthlaw.inventionClinical trial03 medical and health sciences0302 clinical medicineRandomized controlled triallawIntervention (counseling)medicinePhysical therapyAnxiety0501 psychology and cognitive sciences030212 general & internal medicinemedicine.symptombusinessPsychosocialAnxiety disorderInternet Interventions
researchProduct

The number of symptoms at the acute COVID-19 phase is associated with anxiety and depressive long-term post-COVID symptoms: A multicenter study

2021

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19AnxietyAnxiety DisordersTerm (time)Psychiatry and Mental healthClinical PsychologyMulticenter studyInternal medicineHumansMedicineAnxietymedicine.symptombusinessLetter to the EditorJournal of Psychosomatic Research
researchProduct

A meta-analysis of nonrandomized effectiveness studies on outpatient cognitive behavioral therapy for adult anxiety disorders

2012

Abstract Objective The primary aim of this study was to assess the overall effectiveness of individual and group outpatient cognitive behavioral therapy (CBT) for adults with a primary anxiety disorder in routine clinical practice. Method We conducted a random effects meta-analysis of 71 nonrandomized effectiveness studies on outpatient individual and group CBT for adult anxiety disorders. Standardized mean gain effect sizes pre- to posttreatment, and posttreatment to follow-up are reported for disorder-specific symptoms, depression, and general anxiety. The mean dropout from CBT is reported. Results Outpatient CBT was effective in reducing disorder-specific symptoms in completer ( d  = 0.9…

AdultCognitive Behavioral Therapymedicine.medical_treatmentRoutine practicemedicine.diseaseAnxiety DisordersGroup psychotherapyCognitive behavioral therapyPsychiatry and Mental healthClinical PsychologyTreatment OutcomeMeta-analysisOutpatientsmedicineCognitive therapyHumansAnxietymedicine.symptomPsychologyAnxiety disorderDepression (differential diagnoses)Clinical psychologyClinical Psychology Review
researchProduct

Center differences and cross-national invariance in help-seeking for panic disorder. A report from the cross-national collaborative panic study.

1992

Help-seeking behaviour for treatment of panic disorder was investigated in the sample of the Cross-National Collaborative Panic Study Second Phase. A total of 1168 patients were entered into this trial in 14 countries. Although there were significant center differences in prior treatment and utilization of health services there were also similarities. Treatment had been provided mainly by general practitioners. Drug treatment consisted mostly of prescription of classical tranquilizers and had a longer duration than treatment by psychotherapy. Patients with agoraphobic avoidance, past major depression and longer duration of illness used medical and psychiatric treatment facilities more inten…

AdultCross-Cultural ComparisonMalemedicine.medical_specialtyImipramineHealth (social science)Social PsychologyEpidemiologyPharmacotherapyEpidemiologymedicineHumansMedical prescriptionPsychiatryDepression (differential diagnoses)Alprazolambusiness.industryPanic disorderIncidencePanicPatient Acceptance of Health Caremedicine.diseaseHelp-seekingPsychiatry and Mental healthCross-Sectional StudiesPanic DisorderFemalemedicine.symptombusinessAnxiety disorderClinical psychologySocial psychiatry and psychiatric epidemiology
researchProduct